NASDAQ:GUTS Fractyl Health (GUTS) Stock Price, News & Analysis $0.45 -0.02 (-4.02%) As of 02:21 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Fractyl Health Stock (NASDAQ:GUTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fractyl Health alerts:Sign Up Key Stats Today's Range$0.45▼$0.4950-Day Range$0.47▼$0.8152-Week Range$0.38▼$2.45Volume2.01 million shsAverage Volume3.06 million shsMarket Capitalization$71.79 millionP/E RatioN/ADividend YieldN/APrice Target$5.50Consensus RatingHold Company Overview Fractyl Health, Inc. is a clinical-stage biotechnology company focused on developing therapies for metabolic diseases, including obesity and type 2 diabetes. The company is working to address the underlying biology of these conditions and pursue treatments that may provide more durable benefits than chronic dosing alone. Fractyl Health’s technologies include the investigational Revita duodenal mucosal resurfacing (DMR) system, an endoscopic procedure designed to alter the lining of the duodenum and potentially improve metabolic control. The company also has a gene-therapy platform known as Rejuva, which is intended to support sustained production of therapeutic molecules such as glucagon-like peptide-1 (GLP-1) in the body. These programs are investigational and remain subject to clinical and regulatory review. Founded in 2015, Fractyl Health is headquartered in Lexington, Massachusetts. The company was founded by and is led by Niren Murthy, who serves as chief executive officer. Its development efforts are primarily directed toward patients with obesity, type 2 diabetes and related metabolic disorders.AI Generated. May Contain Errors. Read More Fractyl Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScoreGUTS MarketRank™: Fractyl Health scored higher than 52% of companies evaluated by MarketBeat, and ranked 505th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingFractyl Health has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialFractyl Health has a consensus price target of $5.50, representing about 1,077.7% upside from its current price of $0.47.Amount of Analyst CoverageFractyl Health has only been the subject of 2 research reports in the past 90 days.Read more about Fractyl Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Fractyl Health are expected to grow in the coming year, from ($0.53) to ($0.44) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fractyl Health is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fractyl Health is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFractyl Health has a P/B Ratio of 6.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Fractyl Health's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.85% of the float of Fractyl Health has been sold short.Short Interest Ratio / Days to CoverFractyl Health has a short interest ratio ("days to cover") of 1.51, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fractyl Health has recently increased by 21.52%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFractyl Health does not currently pay a dividend.Dividend GrowthFractyl Health does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.18 News SentimentFractyl Health has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Fractyl Health this week, compared to 5 articles on an average week.Search Interest9 people have searched for GUTS on MarketBeat in the last 30 days. This is an increase of 29% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Fractyl Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Fractyl Health insiders have not sold or bought any company stock.Percentage Held by Insiders8.36% of the stock of Fractyl Health is held by insiders.Percentage Held by InstitutionsFractyl Health has minimal institutional ownership at this time.Read more about Fractyl Health's insider trading history. Receive GUTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GUTS Stock News HeadlinesPomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTSSeptember 24 at 5:39 PM | prnewswire.comFractyl Health Stockholders Approve Reverse Stock Split PlanSeptember 24 at 5:11 PM | tipranks.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.September 25 at 1:00 AM | Base Camp Trading (Ad)Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmSeptember 24 at 1:00 PM | globenewswire.comGUTS Investor Alert: Fractyl Health, Inc. Securities Class Action Notice - Contact SueWallStSeptember 24 at 10:09 AM | prnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fractyl Health, Inc. (GUTS)September 24 at 9:24 AM | globenewswire.comRobbins LLP Urges GUTS Stockholders to Contact the Firm for Information About the Class Action Against Fractyl Health, Inc.September 23 at 7:48 PM | globenewswire.comKuehn Law Encourages Investors of Fractyl Health, Inc. to Contact Law FirmSeptember 23 at 5:31 PM | prnewswire.comSee More Headlines GUTS Stock Analysis - Frequently Asked Questions How have GUTS shares performed this year? Fractyl Health's stock was trading at $2.20 on January 1st, 2026. Since then, GUTS stock has decreased by 78.8% and is now trading at $0.4670. How were Fractyl Health's earnings last quarter? Fractyl Health, Inc. (NASDAQ:GUTS) announced its earnings results on Monday, August, 10th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.02. Read the conference call transcript. When did Fractyl Health IPO? Fractyl Health (GUTS) raised $110 million in an initial public offering on Friday, February 2nd 2024. The company issued 7,333,333 shares at $14.00-$16.00 per share. Who are Fractyl Health's major shareholders? Fractyl Health's top institutional shareholders include Nantahala Capital Management LLC (7.09%), Bank of America Corp DE (3.79%), Pale Fire Capital SE (3.14%) and General Catalyst Group Management LLC (3.07%). Insiders that own company stock include Harith Rajagopalan, Jay David Caplan, William Bradley, Ajay Royan, Ian Sheffield and Weber Lara Smith. View institutional ownership trends. How do I buy shares of Fractyl Health? Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fractyl Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fractyl Health investors own include SoFi Technologies (SOFI), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/10/2026Today9/25/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 As of 2 days ago, GUTS's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:GUTS Previous SymbolNASDAQ:GUTS CIK1572616 Webfractyl.com Phone781-902-8800FaxN/AEmployees73Year Founded2010Price Target and Rating Average Price Target for Fractyl Health$5.50 High Price Target$8.00 Low Price Target$2.00 Potential Upside/Downside+1,108.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$140.95 million Net MarginsN/A Pretax MarginN/A Return on Equity-1,362.10% Return on Assets-84.89% Debt Debt-to-Equity Ratio1.41 Current Ratio3.15 Quick Ratio3.15 Sales & Book Value Annual Sales$90 thousand Price / Sales804.74 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book6.50Miscellaneous Outstanding Shares159,180,000Free Float145,873,000Market Cap$72.43 million OptionableN/A Beta2.34 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:GUTS) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
